Taiwan
.avif)
Learn about Cisema’s redesigned website with faster performance, clearer navigation and expanded Asia Pacific coverage.
Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites
As of July 1, 2026, Taiwan has completed its cosmetic GMP rollout, extending mandatory ISO 22716-based manufacturing standards to nearly all cosmetic factories
TFDA Simplifies Drug Clinical Trial Application Requirements Effective July 2026
Taiwan's TFDA will reduce clinical trial submission documents and ease decentralized trial requirements for sponsors from July 1, 2026.
Taiwan Proposes New Online Drug Enforcement Obligations Under Pharmaceutical Affairs Act
New rules expand platform accountability and regulatory oversight, reshaping how pharmaceutical products are promoted, sold, and controlled online.
Taiwan FDA Introduces ICH E9(R1) Estimand Framework into Clinical Trial Review
TFDA adopted ICH E9(R1) guidance on estimands, intercurrent events, missing data, and sensitivity analysis for drug clinical trial management.
Taiwan Abolishes Legacy Cosmetics Review Fees
TFDA eliminates legacy cosmetics review fees, reducing compliance costs for foreign companies.
Get in Touch with our Certifications team
And discover how we can support you in getting your products certified for China.